The Akita and Akimba mice both display hyperglycemia (Figure 1A) but interestingly only the Akimba mice possess elevated levels of SGLT2 mRNA in the eye and kidney (Figure 1B–D) highlighting the potential of SGLT2 as a valid therapeutic target for DR. The gene discussed is SLC5A2; the disease is Hyperglycemia.